Veranova is a leading drug substance CDMO that specializes in the development, manufacturing, and analytical testing of complex small molecules and novel modalities. Headquartered in Devens, Massachusetts, the company has five facilities across the U.S. and the UK. Currently, the company has over 200 drug master files (DMFs) and has completed over 2,000 solid form projects across a range of structurally diverse and complex APIs. Veranova’s custom pharma solutions include analytical method development, chromatography, drug conjugates and linkers, HPAPIs, process development, and tech transfer. The company also offers comprehensive solid form and particle engineering services.